TD1092 is a pan- IAP degrader, degrades cIAP1 , cIAP2 , and XIAP. TD1092 activates Caspase 3/7, and promotes cancer cells apoptosis via IAP degradation. TD1092 inhibits TNFα mediated NF-κB pathway and reduces the phosphorylation of IKK , IkBα, p65, and p38. TD1092 can act as PROTAC , and is used for cancer research.